Title |
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
|
---|---|
Published in |
The Lancet Haematology, October 2019
|
DOI | 10.1016/s2352-3026(19)30157-7 |
Pubmed ID | |
Authors |
Dietrich Wilhelm Beelen, Rudolf Trenschel, Matthias Stelljes, Christoph Groth, Tamás Masszi, Péter Reményi, Eva-Maria Wagner-Drouet, Beate Hauptrock, Peter Dreger, Thomas Luft, Wolfgang Bethge, Wichard Vogel, Fabio Ciceri, Jacopo Peccatori, Friedrich Stölzel, Johannes Schetelig, Christian Junghanß, Christina Grosse-Thie, Mauricette Michallet, Hélène Labussiere-Wallet, Kerstin Schaefer-Eckart, Sabine Dressler, Goetz Ulrich Grigoleit, Stephan Mielke, Christof Scheid, Udo Holtick, Francesca Patriarca, Marta Medeot, Alessandro Rambaldi, Maria Caterina Micò, Dietger Niederwieser, Georg-Nikolaus Franke, Inken Hilgendorf, Nils Rudolf Winkelmann, Domenico Russo, Gérard Socié, Régis Peffault de Latour, Ernst Holler, Daniel Wolff, Bertram Glass, Jochen Casper, Gerald Wulf, Helge Menzel, Nadezda Basara, Maria Bieniaszewska, Gernot Stuhler, Mareike Verbeek, Sandra Grass, Anna Paola Iori, Juergen Finke, Fabio Benedetti, Uwe Pichlmeier, Claudia Hemmelmann, Michael Tribanek, Anja Klein, Heidrun Anke Mylius, Joachim Baumgart, Monika Dzierzak-Mietla, Miroslaw Markiewicz |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 13 | 27% |
United Kingdom | 6 | 12% |
Spain | 3 | 6% |
Mexico | 2 | 4% |
Australia | 2 | 4% |
Saudi Arabia | 2 | 4% |
Thailand | 1 | 2% |
Italy | 1 | 2% |
Algeria | 1 | 2% |
Other | 3 | 6% |
Unknown | 15 | 31% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 33 | 67% |
Scientists | 9 | 18% |
Practitioners (doctors, other healthcare professionals) | 6 | 12% |
Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 116 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 17 | 15% |
Other | 16 | 14% |
Student > Bachelor | 13 | 11% |
Student > Ph. D. Student | 7 | 6% |
Professor | 6 | 5% |
Other | 20 | 17% |
Unknown | 37 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 43 | 37% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 8% |
Biochemistry, Genetics and Molecular Biology | 5 | 4% |
Business, Management and Accounting | 4 | 3% |
Psychology | 3 | 3% |
Other | 10 | 9% |
Unknown | 42 | 36% |